| 言語 |
英語
|
| 著者 |
Sugano Kentaro
Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan the Esomeprazole NSAID Preventive Study Group, Japan
Miwa Hiroto
Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan
Takeuchi Tsutomu
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
|
| 主題 | Esomeprazole; Non-steroidal anti-inflammatory drugs; Peptic ulcer; Safety
|
| 掲載誌名 |
BMC GASTROENTEROLOGY
|
| 巻 | 13
|
| ISSN（Online） | 1471-230X
|
| 発行日 | 2013-03-26
|
| DOI | |
| PubMed ID | |
| 出版者 | BMC
|
| 資料タイプ |
学術雑誌論文
|
| 部局 |
医学部
|
| 備考 | Kentaro Sugano: Advisory Board member (AstraZeneca K.K. and Takeda Pharmaceutical Co. Ltd), service honoraria (Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd, Otsuka Pharmaceutical Co. Ltd, Chugai Pharmaceutical Co. Ltd, MSD K.K. and Takeda Pharmaceutical Co. Ltd).; Yoshikazu Kinoshita: service honoraria (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd and Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K. and Eisai Co. Ltd).; Hiroto Miwa: service honoraria (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd, Dainippon Sumitomo Pharma Co. Ltd and Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K., Dainippon Sumitomo Pharma Co. Ltd and Eisai Co. Ltd and Otsuka Pharmaceutical Co. Ltd).; Tsutomu Takeuchi: service honoraria (Abbott Japan Co. Ltd, Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd, Eisai Co. Ltd, Mitsubishi Tanabe Pharma Co. and Pfizer Japan Inc.) and research grants (Abbott Japan Co. Ltd, Astellas Pharma Inc., Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd, Daiichi Sankyo Co. Ltd, Eisai Co. Ltd, Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Nippon Shinyaku Co. Ltd, Novo Nordisk Pharma Ltd, Otsuka Pharmaceutical Co. Ltd, Pfizer Japan Inc., Sanofi K.K., Santen Pharmaceutical Co. Ltd, Takeda Pharmaceutical Co. Ltd and Teijin Pharma Ltd).; This study was funded by AstraZeneca K.K. (Japan), the manufacturer of esomeprazole. Medical writing services from Anna Mett and Steve Winter of inScience Communications, Springer Healthcare were funded by AstraZeneca K.K. (Japan).
|
